DRUG DEVELOPMENT

We are developing a classic psychedelic drug variation and a novel psychedelic drug to approval.

WHAT WE DO

As part of an academic network, we are at the forefront of psychedelic research in Germany. We are working to improve the availability of psychedelics for clinical and scientific use in Germany.

We are working on the infrastructure for the clinical implementation of psilocybin-assisted treatment for depression and we are planning clinical studies in various psychiatric disorders.

We are working on the development of new psychedelic substances with properties that make them more suitable for routine clinical use.

OVID NEWSLETTER

Sign up for our newsletter and we’ll keep you up to date on
our latest developments!